cheynew, you may have to correct intuition here. We see a number of differences that we seldom saw before.
A) PPHM seems to be able to consolidate its up move from 0.28 above 0.48$ and apparently found sopme grounds in the 0.50+$ range.
B) A Clay chart doesn't bring us down by definition as it did before
C) PPHM kept standing during last week biotech hit.
D) The volume seems to be consistently above 2 Mil shares
E) PPHMP is played with (never saw it short before)
And...and...our UP MOVEMENT has STILL not be explained news-wise. We can speculate:
- Wolchok 2 presentations with PPHM-MSK at AACR ?
- Exosome second proof of concept also 100% accurate up-coming?
- Announcement of an Exosome partnering short-list ?
- Announcement of a partnership for exosomes
- A manufacturing contract (e.g. HALO?), decided but still to be signed?
- Some Biomarker or Bavituximab FDA BTD (can be on MSK pre-clinical)
- ???
But if we go from 0.28 to 0.66 and stall in the 0.50+ range and we did not come back down to 0.28$ in a few days (as it was in the past) then, while we might not know why we went up, we did go up on something of consistence, certainly given the large volume.
The moment whatever that is is made public the PPS will even go up MORE because more then some initiated ones will buy PPHM stock.
Market Data 
Markets 
AI
